Q. Lenacapavir (LEN), a drug recently seen in the news, is primarily used for the prevention of which disease?
Answer: HIV infection
Notes: Recently, the United States Food and Drug Administration (FDA) approved Lenacapavir (LEN), the most advanced medicine yet for HIV prevention. Lenacapavir is an antiretroviral drug used as pre-exposure prophylaxis or PrEP for people who are HIV-negative but at risk. PrEP stands for Pre-Exposure Prophylaxis, a method to prevent HIV infection before exposure. Lenacapavir is taken as an injection just twice a year, making it easier and more discreet than daily pills. It is developed by Gilead Sciences and sold under the brand name Yeztugo.